Dermatology Focus™ - The Fall Edition
Dr. Sewon Kang believes that sustaining dermatology’s future requires intentional investment in young faculty—ensuring the field remains both science-driven and patient-centered. He emphasizes that the Dermatology Foundation’s early-career funding not only helps young investigators thrive but also fuels the innovation essential to the specialty’s progress.
For more than 35 years, Dr. Judith Domínguez-Cherit has advanced the diagnosis and treatment of nail diseases, particularly melanonychia and subungual melanoma. Her work is transforming clinical practice in Latin America and beyond.
Dr. James Taylor, the 2025 recipient of the DF Practitioner of the Year Award, Dr. James Taylor, reflects on his pioneering work in occupational dermatology, landmark studies on toxic exposures, and ongoing leadership in mentoring, patient safety, and the future role of AI in medicine.
Attention Investigators & Innovators
Drive your path to discovery with the research opportunities featured below.
Johnson & Johnson Early Career Innovator Award
The Sanofi-Regeneron Mechanisms of Type 2 Inflammation Award
The DF Skin of Color Society (SOCS) Collaborative Award (also sponsored by Sanofi-Regeneron)
Applications for the Early Career Innovator and Mid-career Awards are now open and will close at midnight (CT) December 1, 2025.
Career Development Award (CDA) renewals also close at midnight (CT) December 1, 2025.
Nominate a Leader in Dermatology
There’s still time to recognize a colleague who exemplifies excellence in dermatology. Nominate a devoted clinician, innovative educator, or inspiring mentor for a 2026 DF Honorary Award. Recipients will be announced in January 2026 and honored at the Annual Meeting in March 2026 in Denver, Colorado.
Submit nomination letters to Erica Gardner by October 26, 2025.
Every practicing dermatologist—and their patients—benefit from new treatments unlocked by research.
Since 1964, the Dermatology Foundation has invested in groundbreaking research leading to new knowledge, treatments, and cures. In 2025, the Foundation continued its investment and awarded over $3.3 million in research funding. This accomplishment is made possible with the ongoing support of our dedicated members, corporate partners, and friends. Their generosity sustains this advancement of patient care.
The Potential of Investigators is Infinite
The Dermatology Foundation invests in early and mid-career researchers with novel ideas and the potential to achieve scientific breakthroughs that lead to new treatments and cures. Our current award recipients are uncovering new knowledge about the topics below, which represent a sample of the Foundation's research portfolio. As science evolves, the potential for more breakthrough research in dermatology expands—and the DF is there to support each step forward.
- Acne and Rosacea
- Allergy
- Atopic Dermatitis
- Auto-immunity
- Blistering Diseases
- Carcinogenesis and Cancer Genetics
- Chemoprevention
- Clinical Trial / Therapeutics
- Contact Dermatitis
- Cutaneous Lymphoma
- Connective Tissue Disease
- Epidemiology and Public Health
- Epidermal Structure and Barrier Function
- Genetic Diseases, Gene Regulation and Gene Therapy
- Growth Factors, Cell Adhesion and Matrix Biology
- Hair Disorders
- Healthcare Delivery
- Immunity and Lymphocyte Biology
- Immunotherapy
- Infectious Disease
- Inflammation
- Melanoma
- Microbiology
- Microbiome
- Mohs Surgery
- Mouse Models
- Non-Melanoma Skin Cancer
- Pediatric Dermatology
- Pharmacology and Drug Development
- Photobiology
- Pigmentation and Melanocyte Biology
- Psoriasis
- Scar
- Skin and Hair Developmental Biology
- Skin of Color
- Stem Cell
- Tissue Regeneration and Wound Healing
- Tumor Immunology
- Vitiligo / Pigmentation
- Women’s Health
There is no such thing as a small contribution; every action creates impact.
Stay Connected
Receive monthly updates on the people and events shaping the future of dermatology.